Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders

This publication has 92 references indexed in Scilit:

• Successful Treatment of Chronic Eosinophilic Pneumonia with Anti-IgE Therapy
  Journal of Korean Medical Science, 2012
• Omalizumab in the treatment of eosinophilic esophagitis and food allergy
  European Journal of Pediatrics, 2011
• Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
  Journal of Allergy and Clinical Immunology, 2010
• Practical approach to the patient with hypereosinophilia
  Journal of Allergy and Clinical Immunology, 2010
• Treatment of a Case of Pediatric Hypereosinophilic Syndrome with Anti-Interleukin-5
  The Journal of Pediatrics, 2009
• Anti-IgE treatment of eosinophil-associated gastrointestinal disorders
  Journal of Allergy and Clinical Immunology, 2007
• Mechanisms of Eosinophilia in the Pathogenesis of Hypereosinophilic Disorders
  Immunology and Allergy Clinics of North America, 2007
• Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody
  Thorax, 2007
• Eosinophils function as antigen-presenting cells
  Journal of Leukocyte Biology, 2004
• IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell Responses
  Immunity, 1996